Mapping outcomes in randomised radiology trials: Protocol for a scoping review
Acta Radiologica Open · 2026-06 · 15 (6)
DOI: 10.1177/20584601261473871 ↗Kurz gefasst
Scoping Review in der Zeitschrift Acta Radiologica Open, online erschienen am 30.07.2026. Verfasst von Benjamin Skov Kaas-Hansen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
This scoping review aims to systematically map how outcomes are defined and operationalised in contemporary radiological randomised clinical trials (RCTs). The findings will inform a subsequent Delphi process to develop a core outcome set for clinical studies in radiology, including adaptive platform trials (APTs), conventional RCTs, and observational studies. Methods including end points The scoping review will be conducted in accordance with PRISMA-P and PRISMA-ScR guidelines and will encompass articles published from 1 January 2023 in select high-impact general medical and radiological journals, using a search strategy developed and vetted by an independent information specialist. The search strategy yielded 4,202 hits on 7 April 2026. All steps, from screening through data extraction, will be done in duplicate by two independent authors. Extracted trial data will include number of trial sites, number of participants, sub-speciality, intervention type, and interventions under study. For each outcome in each trial, we will extract the name and type of the outcome, operationalisation/definition/tool used, assessment of temporality (e.g. truncation, censoring, repeated sampling), missingness proportion, missingness handling, effect quantification, and statistical analyses of effects (e.g. unadjusted or regression-model based). Data extraction will start with a 10-trial pilot phase for maximised data quality. Data synthesis will be descriptive without risk of bias evaluation.
Implications
This scoping review will map how outcomes are defined and operationalised in contemporary radiological RCTs and inform a Delphi process to identify core outcomes for APTs and RCTs, supporting the advancement of value-based radiology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
- Department of Radiology, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
- Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Benjamin Skov Kaas-Hansen, Mia Kolmos, Simona Gentile
Zitieren
APA
Kaas-Hansen, B. S., Müller, C. F., Hansen, M. L., Kolmos, M., Gentile, S., Pehrson, L. M., Offersen, C. J. M., Ingala, S., & Lönn, L. B. (2026). Mapping outcomes in randomised radiology trials: Protocol for a scoping review. Acta Radiologica Open, 15(6). https://doi.org/10.1177/20584601261473871
Vancouver
Kaas-Hansen BS, Müller CF, Hansen ML, Kolmos M, Gentile S, Pehrson LM, et al. Mapping outcomes in randomised radiology trials: Protocol for a scoping review. Acta Radiologica Open. 2026;15(6). doi:10.1177/20584601261473871
BibTeX
@article{KaasHansen2026,
author = {Kaas-Hansen, Benjamin Skov and Müller, Christoph Felix and Hansen, Martin Lundsgaard and Kolmos, Mia and Gentile, Simona and Pehrson, Lea Marie and Offersen, Cecilie Juul Mørck and Ingala, Silvia and Lönn, Lars Birger},
title = {Mapping outcomes in randomised radiology trials: Protocol for a scoping review},
journal = {Acta Radiologica Open},
year = {2026},
volume = {15},
number = {6},
doi = {10.1177/20584601261473871}
}
EUVIMED